Skip to main content
. 2016 Nov 17;6:3–8. doi: 10.1016/j.bonr.2016.11.003

Table 1.

Baseline subject characteristics.

Disease Number Female Median Age [25%–75%] Median Observation Period [25%–75%] Median FRAXa [25%–75%] Bisphosphonates prescription (%) Prior high-dose GC (%) Fragility Fracture (%)
SLE 76 66 (86.8) 30.5 [24–37] 2226 [1124–3085] 5.3 [3.7–10.9] 28 (36.8) 30 (39.5) 6 (7.8)
Vasculitisb 58 45 (75.9) 66 [47.8–70.8] 1166 [618.3–2087] 14 [6.8–24] 38(65.5) 9 (15.5) 18 (31)
PM/DM 51 34 (66.7) 58 [47–69] 1655 [676–2587] 9 [5.9–14] 34 (66.7) 5 (9.8) 18 (35.3)
AOSD 12 7 (58.3) 37.5 [26–56] 1613 [1215–2335] 7.2 [3.2–9.8] 7 (58.3) 1 (8.3) 2 (16.7)
MCTD 7 6 (75) 42 [35–54] 1975 [1768–2540] 5.7 [2.8–10] 6 (85.7) 2 (29) 1 (14.2)
Othersc 25 12 (48) 63 [57.5–70] 833 [283–2650] 6.7 [4.9–13] 9 (36) 4 (16) 12 (48)
Total 229 170 (74.2) 49 [31–66] 1558 [803–2596] 9 [5.2–15] 122 (53.2) 51 (22.2) 57c (24.9)

AOSD = adult-onset Still's disease.

a

FRAX is calculated for postmenopausal women and men over 40 of age.

b

Vasculitis syndromes: Takayasu arteritis (11); giant-cell arteritis (11); microscopic polyangiitis (10); granulomatosis with polyangiitis (7); eosinophilic granulomatosis with polyangiitis (6); Behcet's disease (5); rheumatoid vasculitis (4); unclassified vasculitis (4). bOther diseases: IgG4-related disease (4); Castleman's disease (3); overlap syndrome (3); sarcoidosis (2); diffuse fasciitis (3); systemic sclerosis (2); relapsing polychondritis (2); idiopathic thrombocytopenia (1); autoimmune haemolytic anaemia (1); autoimmune hepatitis (1); eosinophilic pneumonia (1); and pachymeningitis (1).

c

52 clinical spinal, 3 hip, 1 humerus and 1 wrist fracture.

HHS Vulnerability Disclosure